Angiodynamics ANGO
NASDAQ ANGO
$11.89 +0.08 (+0.68%)
At close: Oct 21, 2026 · 4:00 PM EDT

Angiodynamics (ANGO) Research & Development (2010 - 2026)

Updated

Angiodynamics' Research & Development came in at $7.98 million for fiscal Q1 2027 (quarter ended Aug 31, 2026), up 24.3% from $6.42 million a year earlier but down 2.4% from the prior quarter.

Analysis

Angiodynamics (ANGO) Research & Development (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Aug 31, 2026, Angiodynamics reported Research & Development of $31.01 million, up 17.7% year-over-year; for FY2026 (ended May 31, 2026), it was $29.45 million, up 12.3% from FY2025.

  • Research & Development carries a five-year compound annual growth rate of -4.1% (FY2021 to FY2026).
  • Going back by fiscal year, Research & Development was $26.22 million in FY2025 (-16.8%), $31.51 million in FY2024 (+5.5%), $29.88 million in FY2023 (-2.8%) and $30.74 million in FY2022 (-15.5%).
  • The five-year range for quarterly Research & Development is $6.29 million (fiscal Q1 2025) to $8.66 million (fiscal Q2 2024).
  • Year-over-year, Research & Development has increased for five consecutive quarters, with growth averaging 3.8% over the last eight quarters.
  • The fastest year-over-year change in Research & Development over five years came in fiscal Q2 2024 (growth of 26.6%), and the weakest in fiscal Q2 2025 (a decline of 25.7%).
  • Business Quant data shows ANGO's Research & Development at $8.18 million (Q4 2026), $7.08 million (Q3 2026) and $7.77 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn 364.00 Mn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn 892.00 Mn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 412.00 Mn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn 370.60 Mn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn 771.00 Mn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn 434.00 Mn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn 554.00 Mn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn 258.00 Mn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 278.90 Mn
10 Angiodynamics 499.01 Mn 331.73 Mn 48.04 Mn 7.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 7.98 Mn
May 31, 2026 8.18 Mn
Feb 28, 2026 7.08 Mn
Nov 30, 2025 7.77 Mn
Aug 31, 2025 6.42 Mn
May 31, 2025 6.59 Mn
Feb 28, 2025 6.91 Mn
Nov 30, 2024 6.43 Mn
Aug 31, 2024 6.29 Mn
May 31, 2024 6.72 Mn
Feb 29, 2024 8.19 Mn
Nov 30, 2023 8.66 Mn
Aug 31, 2023 7.94 Mn
May 31, 2023 7.86 Mn
Feb 28, 2023 6.85 Mn
Nov 30, 2022 6.84 Mn
Aug 31, 2022 8.33 Mn
May 31, 2022 7.87 Mn
Feb 28, 2022 7.28 Mn
Nov 30, 2021 8.20 Mn
API Access

Angiodynamics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=ANGO&period=max&api_key=YOUR_API_KEY